Chantal A. A. van der Graaf

Toll-Like Receptor 2 Suppresses Immunity against <i>Candida albicans</i> through Induction of IL-10 and Regulatory T Cells

Mihai G. Netea, Roger P.M. Sutmuller, Corinna Hermann et al. · The Journal of Immunology · 2004 · 600 citations · Full text

The Role of Toll‐like Receptor (TLR) 2 and TLR4 in the Host Defense against Disseminated Candidiasis

Mihai G. Netea, Chantal A. A. van der Graaf, Alieke G. Vonk et al. · The Journal of Infectious Diseases · 2002 · 486 citations · Full text

Differential Cytokine Production and Toll-Like Receptor Signaling Pathways by <i>Candida albicans</i> Blastoconidia and Hyphae

Chantal A. A. van der Graaf, Mihai G. Netea, Ineke Verschueren et al. · Infection and Immunity · 2005 · 183 citations · Full text

Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection.

Chantal A. A. van der Graaf, Mihai G. Netea, Servaas A. Morré et al. · PubMed · 2006 · 161 citations

Asp299gly/thr399ile Polymorphisms, Innate Immune System, Immunology +21

Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity

Kalijn F. Bol, Erik H.J.G. Aarntzen, Jeanette M. Pots et al. · Cancer Immunology Immunotherapy · 2016 · 65 citations · Full text